AVIS : Entraves à la circulation sur la rue Saint-Denis les 2, 3 et 4 mars. Merci de prévoir vos déplacements.



Principal scientistCancer


The patient who needs immediate assistance should not communicate directly with the researcher. Instead, they should call the doctor’s office or take other appropriate measures, such as going to the nearest emergency service.


Director Prostate cancer research, Montreal Cancer Institute, CRCHUM

Full professor Department of surgery, Université de Montréal

Uro-oncologist Urology Department, CHUM

Research Chair

Chairholder Chaire Raymond Garneau en cancer de la prostate de l'Université de Montréal / Chair in Prostate Cancer Research, Université de Montréal

Other Affiliations

Principal investigator Alliance-Procure biobank, which brings together the four universities in Quebec

Member Board of Directors of: The Montreal Cancer Institute, National Cancer Institute of Canada, Procure Alliance

President Canadian Urologic Oncology Group (CUOG) and National Cancer Institute of Canada G-U (NCIC G-U)

Secretary Canadian Prostate Health Council and Global G-U

Member of the editorial board Lancet Oncology, JAMA Oncology and Nature Urology

Research Interests

Research on prognostic molecular markers in prostate cancer and hormone-refractory prostate cancer.

Founder of the Oncology Urology Clinic at the University Hospital of Montreal (CHUM) and the Molecular Oncology Laboratory in Prostate Cancer at the Montreal Cancer Institute.


This multidisciplinary theme brings together clinicians, basic researchers and epidemiologists. Its current activities are grouped into six sub-themes. Treatment and chemoprevention  This sub-theme, plays a front line role through the development of new treatments and chemotherapies targeting…

Learn more
Dre Diane Provencher et sa patiente Mme Annie Duranceau